Necessity of adjusting the blood hemoglobin target owing to interdialytic weight gain in patients on maintenance hemodialysis

IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY
Masayuki Tanemoto
{"title":"Necessity of adjusting the blood hemoglobin target owing to interdialytic weight gain in patients on maintenance hemodialysis","authors":"Masayuki Tanemoto","doi":"10.1111/hdi.13108","DOIUrl":null,"url":null,"abstract":"To the Editor: Anemia is a common complication in patients on maintenance hemodialysis, and its correction with erythropoiesis-stimulating agents is an established therapy. Current guidelines indicate the target blood hemoglobin levels for administering erythropoiesisstimulating agents but do not specify the hemoglobin measurement conditions, which reportedly affect hemoglobin in maintenance hemodialysis patients. Notably, hemoglobin decreases in case of hemodilution, such as that caused by interdialytic weight gain, and a difference in the gain would generally result in pre-dialysis hemoglobin measured early in the week (early-week-preHb) being lower than that measured midweek (midweekpre-Hb). However, studies examining this hemoglobin difference are scarce and have reported varying results; the difference was only 0.9% in one study but 4.3% in another. Thus, we aimed to examine this difference. This study was performed at a dialysis center in accordance with the Declaration of Helsinki. Pre-dialysis hemoglobin was measured during consecutive earlyweek and midweek maintenance hemodialysis sessions in 12 patients who were undergoing three maintenance hemodialysis sessions per week and were not on the therapy with erythropoiesis-stimulating agents. Comparisons were performed using Student’s paired t-test. Table 1 summarizes the measurements. The mean and median of the early-week-pre-Hb to midweek-pre-Hb ratio were 96.1% and 96.8%, respectively. Therefore, early-week-pre-Hb was lower than midweek-pre-Hb by approximately 4%. In the present analysis, interdialytic weight gain relative to dry weight—the target weight after a dialysis session (IDWG/DW)—was approximately 5.5% and 4.2% in the early-week and midweek sessions, respectively. This increase reduced early-week-pre-Hb by approximately 4% compared with midweek-pre-Hb. Thus, hemoglobin decreased by approximately 3% per additional 1% increase in IDWG/DW. As the daily IDWG/DW is typically 1.5%, the present findings support the previous finding that early-week-pre-Hb was lower than midweekpre-Hb by approximately 4.5%. Interdialytic weight gain is primarily attributed to increased extracellular fluid. As extracellular fluid accounts for approximately one-third of the total body fluid, which in turn accounts for approximately","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"27 4","pages":"477-478"},"PeriodicalIF":1.2000,"publicationDate":"2023-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hemodialysis International","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hdi.13108","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

To the Editor: Anemia is a common complication in patients on maintenance hemodialysis, and its correction with erythropoiesis-stimulating agents is an established therapy. Current guidelines indicate the target blood hemoglobin levels for administering erythropoiesisstimulating agents but do not specify the hemoglobin measurement conditions, which reportedly affect hemoglobin in maintenance hemodialysis patients. Notably, hemoglobin decreases in case of hemodilution, such as that caused by interdialytic weight gain, and a difference in the gain would generally result in pre-dialysis hemoglobin measured early in the week (early-week-preHb) being lower than that measured midweek (midweekpre-Hb). However, studies examining this hemoglobin difference are scarce and have reported varying results; the difference was only 0.9% in one study but 4.3% in another. Thus, we aimed to examine this difference. This study was performed at a dialysis center in accordance with the Declaration of Helsinki. Pre-dialysis hemoglobin was measured during consecutive earlyweek and midweek maintenance hemodialysis sessions in 12 patients who were undergoing three maintenance hemodialysis sessions per week and were not on the therapy with erythropoiesis-stimulating agents. Comparisons were performed using Student’s paired t-test. Table 1 summarizes the measurements. The mean and median of the early-week-pre-Hb to midweek-pre-Hb ratio were 96.1% and 96.8%, respectively. Therefore, early-week-pre-Hb was lower than midweek-pre-Hb by approximately 4%. In the present analysis, interdialytic weight gain relative to dry weight—the target weight after a dialysis session (IDWG/DW)—was approximately 5.5% and 4.2% in the early-week and midweek sessions, respectively. This increase reduced early-week-pre-Hb by approximately 4% compared with midweek-pre-Hb. Thus, hemoglobin decreased by approximately 3% per additional 1% increase in IDWG/DW. As the daily IDWG/DW is typically 1.5%, the present findings support the previous finding that early-week-pre-Hb was lower than midweekpre-Hb by approximately 4.5%. Interdialytic weight gain is primarily attributed to increased extracellular fluid. As extracellular fluid accounts for approximately one-third of the total body fluid, which in turn accounts for approximately
由于维持性血液透析患者的分析间体重增加,调整血红蛋白目标的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hemodialysis International
Hemodialysis International UROLOGY & NEPHROLOGY-
CiteScore
2.50
自引率
0.00%
发文量
58
审稿时长
6-12 weeks
期刊介绍: Hemodialysis International was originally an annual publication containing the Proceedings of the International Symposium on Hemodialysis held in conjunction with the Annual Dialysis Conference. Since 2003, Hemodialysis International is published quarterly and contains original papers on clinical and experimental topics related to dialysis in addition to the Annual Dialysis Conference supplement. This journal is a must-have for nephrologists, nurses, and technicians worldwide. Quarterly issues of Hemodialysis International are included with your membership to the International Society for Hemodialysis. The journal contains original articles, review articles, and commentary to keep readers completely updated in the field of hemodialysis. Edited by international and multidisciplinary experts, Hemodialysis International disseminates critical information in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信